Exercise Therapy Program in Ankylosing Spondylitis Patients
Effect of Two Exercise Therapy Program With and Without Elastic Resistance in Ankylosing Spondylitis Patients
1 other identifier
interventional
55
1 country
1
Brief Summary
Mobility exercises are used in Ankylosing Spondylitis (AS) patients to preserve and restore axial mobility, but there are no data regarding a specific rehabilitation program that includes flexibility alone and its association with resistance exercises in AS patients with stable disease activity. So, we assessed the effects of two exercise programs in terms of mobility, functional capacity, quality of life and disease activity in AS patients. Methods. Fifty-five sedentary AS patients with a Bath Ankylosing Spondylitis Activity Index (BASDAI) \<4 were included.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jul 2012
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2012
CompletedFirst Submitted
Initial submission to the registry
September 18, 2012
CompletedFirst Posted
Study publicly available on registry
September 21, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2014
CompletedResults Posted
Study results publicly available
October 20, 2016
CompletedOctober 20, 2016
August 1, 2016
11 months
September 18, 2012
January 27, 2016
August 27, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (5)
FUNCTIONAL INDEX
BASFI - Bath ankylosing spondylitis functional index. A scale from 0 to 10 (lower scores means better functional capacity), results are measured by mean and standard deviation.
Baseline and 16 Weeks
Mobility Index
Bath ankylosing spondylitis motion index. A mean of five mobility measures committed by Ankylosing Spondylitis disease. Higher results means higher limitations in mobility (units of measure from 0 to 10)
Baseline and 16 weeks
Disease Activity Index
BASDAI - Bath ankylosing spondylitis disease activity index. Scale from 0 to 6. Higher scores means worst disease activity. Numbers are expressed in average (SD)
Baseline and 16 Weeks
Ankylosing Spondylitis Disease Activity Scale -Disease Activity
Scores vary from 0 to 10, and higher than 4 scores are indicative of disease activity. Data are expressed by means and SD
Baseline and 16 Weeks
Global Evaluation Self Reported
Bath Ankylosing Spondylitis Global is a self reported global score varying from 0 to 10. Higher scores means worst health evaluation. Expressed by means and standard deviation.
Baseline and 16 Weeks
Secondary Outcomes (10)
Thoracolumbar Mobility
Baseline and 16 Weeks
Pain Scale
Baseline and 16 Weeks
Stiffness Scale
Baseline and 16 Weeks
Short Form-12 (PCS)
Baseline and 16 Weeks
Short Form-12 (MCS)
Baseline and 16 Weeks
- +5 more secondary outcomes
Study Arms (3)
ankylosing spondylitis control
NO INTERVENTIONcontrol group
mobility exercise
EXPERIMENTALmobility exercises
mobility and elastic resistance exercise
EXPERIMENTALAS patients was submitted to a program mobility exercise plus elastic resistance exercises
Interventions
30 minutes, twice a week each exercises group. (total 1 hour)
Eligibility Criteria
You may qualify if:
- Ankylosing spondylitis patient
- Basdai index lower than 4
- Physical inactive
- Functional class I to III
You may not qualify if:
- Fibromyalgia
- Cardiovascular disease
- Pain Visual Analogue Scale ("VAS") over 8
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Sao Paulo
São Paulo, São Paulo, 05403-010, Brazil
Related Publications (1)
Yigit S, Sahin Z, Demir SE, Aytac DH. Home-based exercise therapy in ankylosing spondylitis: short-term prospective study in patients receiving tumor necrosis factor alpha inhibitors. Rheumatol Int. 2013 Jan;33(1):71-7. doi: 10.1007/s00296-011-2344-6. Epub 2012 Jan 5.
PMID: 22218641RESULT
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Results Point of Contact
- Title
- Andrea Lopes Gallinaro; Researcher
- Organization
- Universidade Sao Paulo
Study Officials
- STUDY CHAIR
Ana Lucia Pinto, Phd
University of Sao Paulo
Publication Agreements
- PI is Sponsor Employee
- Yes
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MASTER
Study Record Dates
First Submitted
September 18, 2012
First Posted
September 21, 2012
Study Start
July 1, 2012
Primary Completion
June 1, 2013
Study Completion
November 1, 2014
Last Updated
October 20, 2016
Results First Posted
October 20, 2016
Record last verified: 2016-08
Data Sharing
- IPD Sharing
- Will share
paper is been written